Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
17.10
+0.10 (0.59%)
At close: Dec 5, 2025
SHA:600161 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 33,813 | 40,536 | 50,983 | 39,103 | 39,767 | 52,310 | Upgrade
|
| Market Cap Growth | -24.54% | -20.49% | 30.38% | -1.67% | -23.98% | 79.10% | Upgrade
|
| Enterprise Value | 35,630 | 38,978 | 49,023 | 37,846 | 37,744 | 52,384 | Upgrade
|
| Last Close Price | 17.10 | 20.23 | 25.32 | 19.38 | 19.63 | 28.19 | Upgrade
|
| PE Ratio | 25.93 | 26.17 | 45.94 | 44.39 | 52.33 | 81.86 | Upgrade
|
| Forward PE | 20.48 | 29.48 | 39.63 | 39.14 | 45.04 | 67.68 | Upgrade
|
| PS Ratio | 5.26 | 6.72 | 9.84 | 9.18 | 9.67 | 15.18 | Upgrade
|
| PB Ratio | 2.26 | 2.79 | 4.00 | 3.44 | 3.87 | 8.67 | Upgrade
|
| P/TBV Ratio | 3.38 | 4.20 | 5.69 | 4.78 | 5.27 | 12.60 | Upgrade
|
| P/FCF Ratio | - | - | 38.74 | - | - | 561.25 | Upgrade
|
| P/OCF Ratio | - | 49.45 | 21.30 | 34.73 | 40.56 | 74.51 | Upgrade
|
| PEG Ratio | 4.10 | 2.21 | 2.21 | 2.21 | 2.21 | 2.21 | Upgrade
|
| EV/Sales Ratio | 5.55 | 6.46 | 9.46 | 8.88 | 9.18 | 15.20 | Upgrade
|
| EV/EBITDA Ratio | 14.24 | 14.04 | 25.08 | 26.07 | 28.75 | 44.33 | Upgrade
|
| EV/EBIT Ratio | 16.69 | 15.77 | 28.73 | 29.27 | 32.15 | 49.94 | Upgrade
|
| EV/FCF Ratio | -31.10 | - | 37.25 | - | - | 562.04 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.00 | 0.00 | 0.04 | 0.05 | 0.13 | Upgrade
|
| Debt / EBITDA Ratio | 0.09 | 0.02 | 0.02 | 0.27 | 0.38 | 0.68 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.03 | - | - | 8.59 | Upgrade
|
| Asset Turnover | 0.40 | 0.40 | 0.38 | 0.35 | 0.43 | 0.50 | Upgrade
|
| Inventory Turnover | 0.92 | 0.82 | 0.99 | 0.97 | 1.00 | 0.85 | Upgrade
|
| Quick Ratio | 3.06 | 3.41 | 3.66 | 4.25 | 6.65 | 2.62 | Upgrade
|
| Current Ratio | 6.01 | 6.89 | 5.92 | 6.28 | 9.32 | 4.96 | Upgrade
|
| Return on Equity (ROE) | 12.54% | 15.48% | 12.52% | 11.14% | 13.12% | 16.83% | Upgrade
|
| Return on Assets (ROA) | 8.31% | 10.28% | 7.87% | 6.59% | 7.68% | 9.46% | Upgrade
|
| Return on Capital (ROIC) | 9.18% | 11.28% | 8.69% | 7.17% | 8.33% | 10.56% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.10% | 16.80% | 13.20% | 11.00% | 10.90% | 15.90% | Upgrade
|
| Earnings Yield | 3.89% | 3.82% | 2.18% | 2.25% | 1.91% | 1.22% | Upgrade
|
| FCF Yield | -3.39% | -0.61% | 2.58% | -0.58% | -0.38% | 0.18% | Upgrade
|
| Dividend Yield | 0.88% | 0.49% | 0.49% | 0.21% | 0.35% | 0.25% | Upgrade
|
| Payout Ratio | 37.54% | 15.96% | 8.47% | 17.85% | 21.56% | 14.54% | Upgrade
|
| Buyback Yield / Dilution | -0.21% | -0.21% | 0.62% | -2.79% | -7.41% | -0.59% | Upgrade
|
| Total Shareholder Return | 0.67% | 0.28% | 1.12% | -2.57% | -7.06% | -0.35% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.